<DOC>
	<DOCNO>NCT00904423</DOCNO>
	<brief_summary>Aromatase inhibitor potent suppressor breast cancer growth , side effect include bone loss , fracture , arthralgias myalgia . We hypothesize vitamin D administration might beneficial treat symptom protect bone .</brief_summary>
	<brief_title>Ph I/II Vitamin D Bone Mineral Density &amp; Markers Bone Resorption</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Bone Resorption</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>3.1.1 All postmenopausal woman histologyconfirmed invasive primary breast cancer , complete primary surgical radiotherapy ( XRT ) without adjuvant chemotherapy candidate receive adjuvant therapy aromatase inhibitor screen eligibility . Postmenopausal define satisfy one follow criterion : bilateral oophorectomy ; age 60 year ; age 5559 year intact uterus amenorrheic least 12 month ; amenorrheic less 12 month ( receive hysterectomy , hormone therapy chemotherapy ) . 3.1.2 At time study enrollment , participant complete primary surgical XRT without adjuvant chemotherapy . Chemotherapy complete least 28 day prior enrollment . 3.1.4 Participants woman 1885 year age . Women minorities actively recruit . Though breast cancer extremely rarely occur child men , study recruit adult female . 3.1.5 Participants life expectancy least 5 year . 3.1.6 Participants Eastern Clinical Oncology Group ( ECOG ) performance status 02 . 3.1.7 Ability understand willingness sign write informed consent document 3.2.1 Medications affect bone metabolism ( bisphosphonates , anticonvulsant , chronic heparin therapy , chronic glucocorticoid use &gt; 5 mg/day prednisone equivalent , teriparatide ) . 3.2.2 Use investigational drug within past 90 day . 3.2.3 Metastatic breast cancer . High risk osteoporosis/fractures ( BMD &lt; 2.0 , history nontraumatic fracture ) . Hyperparathyroidism Hypercalcemia Hypercalciuria ( fast spot urine calcium/creatinine ratio &gt; 0.20 ) History renal stone Renal failure creatinine 2.0 3.2.4 Considering vitamin D3 produce human body , allergy vitamin D3 expect develop . Subjects know history allergic reaction compound used manufacture capsule ( rice powder ) exclude form study . 3.2.5 Recent history excessive alcohol drug use . 3.2.6 As study recruit postmenopausal patient , thus pregnant nursing patient part investigation . 3.2.8 This study design study woman complete primary therapy breast cancer . Survivors previous cancer HIVpositive subject exclude .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>